Related Experiment Video
Updated: Sep 13, 2025

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
Published on: April 11, 2016
The Role of Microbial Exopolysaccharides in Preventing and Treating Cardiovascular Diseases
Enrique A Sanhueza-Carrera1,2, Cassiopeia Cantero-Ramírez1, Angel D Montijo-Valdés1
1Laboratorio de Biomoléculas y Salud Infantil, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.
Insights
Exopolysaccharides (EPSs) show promise as natural compounds for managing cardiovascular diseases (CVDs). These bioactive agents offer cardioprotective effects, acting as antioxidants and regulating blood pressure and cholesterol.
Area of Science:
- Biochemistry
- Pharmacology
- Biotechnology
Background:
- Cardiovascular diseases (CVDs) are a leading global health crisis, causing significant mortality and disability.
- Current pharmacological treatments for CVDs have limitations and side effects, necessitating alternative therapies.
Purpose of the Study:
- To review the properties of exopolysaccharides (EPSs) as bioactive agents for cardiovascular health.
- To highlight the mechanisms of EPSs in cardioprotection, including antioxidant, antihypertensive, and cholesterol-regulating effects.
Main Methods:
- Literature review of studies on exopolysaccharides and cardiovascular diseases.
- Analysis of cellular signaling pathways involved in EPSs' cardioprotective actions.
Main Results:
- EPSs exhibit antioxidant properties, mitigating oxidative stress in cardiovascular conditions.
- EPSs demonstrate antihypertensive effects and contribute to cholesterol regulation.
- EPSs promote regenerative effects on vascular epithelia, supporting vascular health.
Conclusions:
- Exopolysaccharides are promising biomolecules for the prevention and management of cardiovascular diseases.
- EPSs offer a natural, potentially safer alternative or complementary therapy for CVDs.
Abstract:
Cardiovascular diseases (CVDs) have become one of the major global health crises of the last century, causing millions of deaths each year, and are the leading cause of disability worldwide. The pharmacological management of these conditions demands new alternative or complementary therapies due to the multiple long-term side effects experienced by patients. In this context, exopolysaccharides (EPSs) have emerged as a promising alternative due to their numerous functional properties and favorable biotechnological and medical applications for health. This review provides an overview of the properties of EPSs as bioactive agents in cardiovascular diseases, highlighting the cellular signaling mechanisms in their role as cardioprotective agents, with a primary focus on their roles as antioxidants, antihypertensives, and cholesterol regulators, and their regenerative effects on vascular epithelia, positioning EPSs as promising biomolecules for CVD prevention.
Related Concept Videos
Biofilms
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Atherosclerosis III: Management
Glycocalyx and its Functions
Biosynthesis of Polysaccharides
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

